Your browser doesn't support javascript.
loading
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia.
Horak, Peter; Uhrig, Sebastian; Witzel, Maximilian; Gil-Farina, Irene; Hutter, Barbara; Rath, Tim; Gieldon, Laura; Balasubramanian, Gnana Prakash; Pastor, Xavier; Heilig, Christoph E; Richter, Daniela; Schröck, Evelin; Ball, Claudia R; Brors, Benedikt; Braun, Christian J; Albert, Michael H; Scholl, Claudia; von Kalle, Christof; Schmidt, Manfred; Fröhling, Stefan; Klein, Christoph; Glimm, Hanno.
Affiliation
  • Horak P; German Cancer Consortium (DKTK), Heidelberg, Germany. peter.horak@nct-heidelberg.de.
  • Uhrig S; Division of Translational Medical Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.
  • Witzel M; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Gil-Farina I; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Hutter B; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Rath T; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany.
  • Gieldon L; Division of Translational Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany.
  • Balasubramanian GP; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Pastor X; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Heilig CE; Division of Translational Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany.
  • Richter D; GeneWerk GmbH, Heidelberg, Germany.
  • Schröck E; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Ball CR; German Cancer Consortium (DKTK) Dresden and DKFZ, Heidelberg, Germany.
  • Brors B; NCT Dresden, Dresden, Germany.
  • Braun CJ; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Albert MH; Division of Pediatric Neurooncology, DKFZ, Heidelberg, Germany.
  • Scholl C; Division of Theoretical Bioinformatics, DKFZ, Heidelberg, Germany.
  • von Kalle C; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Heidelberg, Germany.
  • Schmidt M; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Fröhling S; Division of Translational Medical Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany.
  • Klein C; Department of Translational Medical Oncology, NCT Dresden, Dresden, Germany.
  • Glimm H; University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Leukemia ; 34(10): 2785-2789, 2020 10.
Article de En | MEDLINE | ID: mdl-32127638

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thérapie génétique / Seconde tumeur primitive / Génomique / Leucémie-lymphome lymphoblastique à précurseurs T Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2020 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thérapie génétique / Seconde tumeur primitive / Génomique / Leucémie-lymphome lymphoblastique à précurseurs T Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2020 Type de document: Article Pays d'affiliation: Allemagne
...